期刊文献+

As_2O_3联合维生素C治疗初发急性早幼粒细胞白血病的临床观察

Clinical observation of arsenic trioxide combined with vitamin C in treatment of patients with previously acute promyelocytic leukemia
原文传递
导出
摘要 目的观察三氧化二砷(As2O3)联合维生素C对初发急性早幼粒细胞白血病(APL)患者的疗效及不良反应。方法采用随机对照研究观察As2O3联合维生素C(治疗组)及单用As2O3(对照组)治疗初发APL患者的完全缓解率、达完全缓解的时间及两组药物不良反应。结果两组患者完全缓解率皆为95%,治疗组达完全缓解的时间明显小于对照组,差异有统计学意义(P<0.05),而两组的药物不良反应差异无统计学意义(P>0.05)。结论 As2O3联合维生素C用于初发APL患者,疗效更好。 Objective To investigate the efficacy and side effects of arsenic trioxide(As2O3) combined with vitamin C for adult acute promyelocytic leukemia(APL). Methods In the randomized controlled trials,to observe the complete remission(CR) and the time to CR and adverse effects of treatment group(As2O3) combined with vitamin C) and control group(uses As2O3 only). Results The complete remission rates of both groups were 95%, the time to CR of treatment group was shorter than the control group, the two groups were obviously different(P〈0.05 ). The adverse reactions to drug of two groups were not different significantly(P〈0. 05). Conclusion For adult APL induction with As2 O3 and vitamin C combination can obtain a shorter time to CR.
出处 《中国误诊学杂志》 CAS 2011年第22期5303-5305,共3页 Chinese Journal of Misdiagnostics
关键词 白血病 早幼粒细胞 急性/药物疗法 砷剂/治疗应用 氧化物/治疗应用 抗坏血酸/治疗应用 Leukemia, Promyelocytic, Acute/drug therapy Arsenicals/therapeutic use Oxides/therapeutic use Ascotbic Acid/therapeutic use
  • 相关文献

参考文献11

二级参考文献51

  • 1马军,展昭民,梁红,贡铁军,唐庆华,任实,郝文鹏,靳明华,夏国强,邵秀茹,王来慈,张伯龙.三氧化二砷治疗复发难治性急性早幼粒细胞白血病临床疗效观察[J].癌症进展,2005,3(2):98-101. 被引量:7
  • 2马军.三氧化二砷在白血病治疗中的临床应用[J].中国医刊,2004,39(10):27-29. 被引量:11
  • 3王振义.开展砷剂治疗白血病的临床和机制研究[J].中华血液学杂志,1996,17(2):57-57. 被引量:100
  • 4张亭栋 李元善.癌灵一号治疗急性粒细胞白血病临床分析及实验研究[J].中西医结合杂志,1984,4(1):19-19. 被引量:5
  • 5Fenaux P,Castaigne S,Dombret H,et al.All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia:a pilot study on 26 cases.Blood,1992,80:2176-2181. 被引量:1
  • 6Muindi J,Frankel SR,Miller WH,et al.Continuous treatment with all-trans tetinoic acid causes a progressive reduction in plasma drug concentration:implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.Blood,1992,79:299-303. 被引量:1
  • 7Sanz MA,Lo CocoF,Martin G,et al.Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia:a joint study of the PETHEMA and GIMEMA cooperative groups.Blood,2000,96:1247-1253. 被引量:1
  • 8Shen ZX,Chen GQ,Wi JH,et al.Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL),Ⅱ.clinical efficacy and pharmacokinetics in relapesed patients.Blood,1997,89:3354-3360. 被引量:1
  • 9Mathews V,George B,Lakshmi KM,et al.Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia:durable remissions with minimal toxicity.Blood,2006,107:2627-2632. 被引量:1
  • 10Gianni M,Koken M,Chelbi-Alix MK,et al.Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells.Blood,1998,91:4300-4310. 被引量:1

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部